Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothea Buck

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 7, 2013
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRIMark Mühlau, Dorothea Buck, Annette Förschler, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 9, 2015
Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's diseasePanagiotis Alexopoulos, Jennifer Roesler, Nathalie Thierjung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2012
18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesionsDorothea Buck, Annette Förschler, Constantin Lapa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2017
Fatigue in multiple sclerosis: Associations with clinical, MRI and CSF parametersViola Biberacher, Paul Schmidt, Rebecca C Selter, et al.
Brain, Behavior, and Immunity|April 14, 2010
Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11beta-hydroxysteroid dehydrogenases in multiple sclerosis: implications for lesion pathogenesisClaudia Heidbrink, Sebastian F M Häusler, Mathias Buttmann, et al.
Plos Pathogens|April 26, 2014
JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variantsEmilie Sundqvist, Dorothea Buck, Clemens Warnke, et al.
Acta Neuropathologica|July 8, 2016
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashionStephanie Hucke, Martin Herold, Marie Liebmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2018
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trialsDorothea Buck, Till Fm Andlauer, Wilmar Igl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2013
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohortTomas Olsson, Anat Achiron, Lars Alfredsson, et al.
Plos One|November 3, 2016
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort AnalysisDelphine Bachelet, Signe Hässler, Cyprien Mbogning, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 7, 2013
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRIMark Mühlau, Dorothea Buck, Annette Förschler, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 9, 2015
Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's diseasePanagiotis Alexopoulos, Jennifer Roesler, Nathalie Thierjung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2012
18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesionsDorothea Buck, Annette Förschler, Constantin Lapa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2017
Fatigue in multiple sclerosis: Associations with clinical, MRI and CSF parametersViola Biberacher, Paul Schmidt, Rebecca C Selter, et al.
Brain, Behavior, and Immunity|April 14, 2010
Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11beta-hydroxysteroid dehydrogenases in multiple sclerosis: implications for lesion pathogenesisClaudia Heidbrink, Sebastian F M Häusler, Mathias Buttmann, et al.
Plos Pathogens|April 26, 2014
JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variantsEmilie Sundqvist, Dorothea Buck, Clemens Warnke, et al.
Acta Neuropathologica|July 8, 2016
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashionStephanie Hucke, Martin Herold, Marie Liebmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2018
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trialsDorothea Buck, Till Fm Andlauer, Wilmar Igl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2013
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohortTomas Olsson, Anat Achiron, Lars Alfredsson, et al.
Plos One|November 3, 2016
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort AnalysisDelphine Bachelet, Signe Hässler, Cyprien Mbogning, et al.
Pageof 4